nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—NR3C1—polycystic ovary syndrome	0.808	1	CbGaD
Fluocinonide—SMO—embryo—polycystic ovary syndrome	0.00997	0.099	CbGeAlD
Fluocinonide—SMO—adrenal cortex—polycystic ovary syndrome	0.00817	0.0812	CbGeAlD
Fluocinonide—NR3C1—urine—polycystic ovary syndrome	0.00744	0.0739	CbGeAlD
Fluocinonide—SMO—endometrium—polycystic ovary syndrome	0.00729	0.0725	CbGeAlD
Fluocinonide—SMO—uterus—polycystic ovary syndrome	0.00672	0.0668	CbGeAlD
Fluocinonide—SMO—pituitary gland—polycystic ovary syndrome	0.0066	0.0656	CbGeAlD
Fluocinonide—SMO—adipose tissue—polycystic ovary syndrome	0.00657	0.0653	CbGeAlD
Fluocinonide—SMO—adrenal gland—polycystic ovary syndrome	0.0059	0.0586	CbGeAlD
Fluocinonide—SMO—female gonad—polycystic ovary syndrome	0.0055	0.0546	CbGeAlD
Fluocinonide—SMO—vagina—polycystic ovary syndrome	0.00546	0.0543	CbGeAlD
Fluocinonide—SMO—endocrine gland—polycystic ovary syndrome	0.00511	0.0508	CbGeAlD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—FST—polycystic ovary syndrome	0.00435	0.0541	CbGpPWpGaD
Fluocinonide—SERPINA6—pituitary gland—polycystic ovary syndrome	0.00364	0.0361	CbGeAlD
Fluocinonide—SMO—GPCRs, Other—ADRA1D—polycystic ovary syndrome	0.00326	0.0406	CbGpPWpGaD
Fluocinonide—SERPINA6—adrenal gland—polycystic ovary syndrome	0.00325	0.0323	CbGeAlD
Fluocinonide—SERPINA6—endocrine gland—polycystic ovary syndrome	0.00282	0.028	CbGeAlD
Fluocinonide—SMO—GPCRs, Other—FSHR—polycystic ovary syndrome	0.00263	0.0327	CbGpPWpGaD
Fluocinonide—NR3C1—embryo—polycystic ovary syndrome	0.0024	0.0239	CbGeAlD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—SCT—polycystic ovary syndrome	0.00222	0.0276	CbGpPWpGaD
Fluocinonide—NR3C1—adrenal cortex—polycystic ovary syndrome	0.00197	0.0196	CbGeAlD
Fluocinonide—NR3C1—endometrium—polycystic ovary syndrome	0.00176	0.0175	CbGeAlD
Fluocinonide—NR3C1—uterus—polycystic ovary syndrome	0.00162	0.0161	CbGeAlD
Fluocinonide—NR3C1—pituitary gland—polycystic ovary syndrome	0.00159	0.0158	CbGeAlD
Fluocinonide—NR3C1—adipose tissue—polycystic ovary syndrome	0.00159	0.0158	CbGeAlD
Fluocinonide—NR3C1—adrenal gland—polycystic ovary syndrome	0.00142	0.0141	CbGeAlD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—INSR—polycystic ovary syndrome	0.00138	0.0172	CbGpPWpGaD
Fluocinonide—NR3C1—female gonad—polycystic ovary syndrome	0.00133	0.0132	CbGeAlD
Fluocinonide—NR3C1—vagina—polycystic ovary syndrome	0.00132	0.0131	CbGeAlD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00129	0.0161	CbGpPWpGaD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—polycystic ovary syndrome	0.00127	0.0158	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—ADRB2—polycystic ovary syndrome	0.00125	0.0155	CbGpPWpGaD
Fluocinonide—NR3C1—endocrine gland—polycystic ovary syndrome	0.00123	0.0123	CbGeAlD
Fluocinonide—SMO—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00122	0.0152	CbGpPWpGaD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—GNAS—polycystic ovary syndrome	0.0012	0.0149	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—polycystic ovary syndrome	0.00115	0.0143	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog 'off' state—GNAS—polycystic ovary syndrome	0.00109	0.0136	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—polycystic ovary syndrome	0.00109	0.0135	CbGpPWpGaD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—polycystic ovary syndrome	0.00103	0.0127	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00102	0.0127	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00102	0.0127	CbGpPWpGaD
Fluocinonide—SMO—Signaling by Hedgehog—GNAS—polycystic ovary syndrome	0.000975	0.0121	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000952	0.0118	CbGpPWpGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—polycystic ovary syndrome	0.000928	0.0115	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000925	0.0115	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.000924	0.0115	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000899	0.0112	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000898	0.0112	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—LIFR—polycystic ovary syndrome	0.000869	0.0108	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000825	0.0103	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000745	0.00927	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.000734	0.00913	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—IRS2—polycystic ovary syndrome	0.00073	0.00908	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—polycystic ovary syndrome	0.000715	0.00889	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—LIF—polycystic ovary syndrome	0.000709	0.00881	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—RETN—polycystic ovary syndrome	0.000709	0.00881	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000698	0.00868	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000682	0.00847	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—NAMPT—polycystic ovary syndrome	0.000675	0.0084	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000656	0.00816	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000652	0.00811	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000648	0.00806	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—AR—polycystic ovary syndrome	0.000642	0.00798	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—IRS1—polycystic ovary syndrome	0.000638	0.00793	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000634	0.00788	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000626	0.00778	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—polycystic ovary syndrome	0.000622	0.00774	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.00062	0.00771	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00061	0.00759	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00061	0.00759	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000607	0.00755	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000595	0.00739	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00058	0.00721	CbGpPWpGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—polycystic ovary syndrome	0.000573	0.00712	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000566	0.00704	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000522	0.0065	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000522	0.0065	CbGpPWpGaD
Fluocinonide—Difluprednate—NR3C1—polycystic ovary syndrome	0.000522	0.0476	CrCbGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.000507	0.00631	CbGpPWpGaD
Fluocinonide—Clocortolone—NR3C1—polycystic ovary syndrome	0.000506	0.0462	CrCbGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000493	0.00613	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000493	0.00613	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—AR—polycystic ovary syndrome	0.000492	0.00611	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000489	0.00608	CbGpPWpGaD
Fluocinonide—Desonide—NR3C1—polycystic ovary syndrome	0.000479	0.0437	CrCbGaD
Fluocinonide—Diflorasone—NR3C1—polycystic ovary syndrome	0.000479	0.0437	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000474	0.0059	CbGpPWpGaD
Fluocinonide—Desoximetasone—NR3C1—polycystic ovary syndrome	0.000467	0.0426	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000462	0.00574	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TH—polycystic ovary syndrome	0.000442	0.0055	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TCF7L2—polycystic ovary syndrome	0.000438	0.00544	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000428	0.00532	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000423	0.00526	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00042	0.00522	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—NCOR1—polycystic ovary syndrome	0.000417	0.00519	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000415	0.00516	CbGpPWpGaD
Fluocinonide—Flurandrenolide—NR3C1—polycystic ovary syndrome	0.000409	0.0373	CrCbGaD
Fluocinonide—Flumethasone Pivalate—NR3C1—polycystic ovary syndrome	0.000402	0.0367	CrCbGaD
Fluocinonide—NR3C1—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.000402	0.005	CbGpPWpGaD
Fluocinonide—Halobetasol Propionate—NR3C1—polycystic ovary syndrome	0.000396	0.0361	CrCbGaD
Fluocinonide—Fluticasone Propionate—PGR—polycystic ovary syndrome	0.00039	0.0356	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000382	0.00475	CbGpPWpGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—polycystic ovary syndrome	0.00037	0.0046	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NPB—polycystic ovary syndrome	0.00037	0.0046	CbGpPWpGaD
Fluocinonide—Budesonide—NR3C1—polycystic ovary syndrome	0.000368	0.0336	CrCbGaD
Fluocinonide—Amcinonide—NR3C1—polycystic ovary syndrome	0.000368	0.0336	CrCbGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000367	0.00456	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000362	0.0045	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—PRL—polycystic ovary syndrome	0.000362	0.0045	CbGpPWpGaD
Fluocinonide—Fluticasone furoate—NR3C1—polycystic ovary syndrome	0.000361	0.0329	CrCbGaD
Fluocinonide—Betamethasone—PGR—polycystic ovary syndrome	0.000357	0.0326	CrCbGaD
Fluocinonide—SMO—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000354	0.0044	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.000351	0.00436	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—polycystic ovary syndrome	0.00035	0.00436	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00035	0.00435	CbGpPWpGaD
Fluocinonide—Mometasone—NR3C1—polycystic ovary syndrome	0.00035	0.0319	CrCbGaD
Fluocinonide—Rimexolone—NR3C1—polycystic ovary syndrome	0.000346	0.0316	CrCbGaD
Fluocinonide—NR3C1—Adipogenesis—NAMPT—polycystic ovary syndrome	0.000339	0.00422	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000337	0.00419	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000334	0.00416	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000333	0.00414	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000329	0.00408	CbGpPWpGaD
Fluocinonide—Beclomethasone—NR3C1—polycystic ovary syndrome	0.000326	0.0298	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000325	0.00404	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—LMNA—polycystic ovary syndrome	0.000322	0.004	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000318	0.00395	CbGpPWpGaD
Fluocinonide—Fluocinolone Acetonide—NR3C1—polycystic ovary syndrome	0.000317	0.0289	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000312	0.00388	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000309	0.00384	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000309	0.00384	CbGpPWpGaD
Fluocinonide—Flunisolide—NR3C1—polycystic ovary syndrome	0.000309	0.0282	CrCbGaD
Fluocinonide—Clobetasol propionate—NR3C1—polycystic ovary syndrome	0.000309	0.0282	CrCbGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000306	0.00381	CbGpPWpGaD
Fluocinonide—Paramethasone—NR3C1—polycystic ovary syndrome	0.000305	0.0278	CrCbGaD
Fluocinonide—Ciclesonide—NR3C1—polycystic ovary syndrome	0.0003	0.0274	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000297	0.0037	CbGpPWpGaD
Fluocinonide—Fluorometholone—NR3C1—polycystic ovary syndrome	0.000297	0.0271	CrCbGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—BAX—polycystic ovary syndrome	0.000295	0.00367	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000289	0.00359	CbGpPWpGaD
Fluocinonide—Methylprednisolone—NR3C1—polycystic ovary syndrome	0.000288	0.0262	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00028	0.00348	CbGpPWpGaD
Fluocinonide—Clobetasol propionate—CYP1A1—polycystic ovary syndrome	0.00028	0.0256	CrCbGaD
Fluocinonide—Dexamethasone—CYP17A1—polycystic ovary syndrome	0.00028	0.0256	CrCbGaD
Fluocinonide—NR3C1—Adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000278	0.00345	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP11A1—polycystic ovary syndrome	0.000276	0.0252	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000273	0.00339	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000271	0.00337	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.00027	0.00336	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—SERPINE1—polycystic ovary syndrome	0.000269	0.00335	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—polycystic ovary syndrome	0.000267	0.00332	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000266	0.0033	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—SLC2A4—polycystic ovary syndrome	0.000262	0.00326	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000248	0.00308	CbGpPWpGaD
Fluocinonide—Betamethasone—CYP19A1—polycystic ovary syndrome	0.000245	0.0224	CrCbGaD
Fluocinonide—Triamcinolone—NR3C1—polycystic ovary syndrome	0.000242	0.0221	CrCbGaD
Fluocinonide—NR3C1—Gene Expression—ZNF205—polycystic ovary syndrome	0.000237	0.00295	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ZNF430—polycystic ovary syndrome	0.000237	0.00295	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000233	0.0029	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000226	0.00281	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000221	0.00275	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00022	0.00273	CbGpPWpGaD
Fluocinonide—Fluticasone Propionate—NR3C1—polycystic ovary syndrome	0.000217	0.0198	CrCbGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—polycystic ovary syndrome	0.000214	0.00266	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000212	0.00264	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—NCOR1—polycystic ovary syndrome	0.00021	0.00261	CbGpPWpGaD
Fluocinonide—Dexamethasone—PGR—polycystic ovary syndrome	0.000208	0.019	CrCbGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000207	0.00258	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000207	0.00257	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ADARB1—polycystic ovary syndrome	0.000202	0.00251	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FST—polycystic ovary syndrome	0.000201	0.0025	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000199	0.00247	CbGpPWpGaD
Fluocinonide—Betamethasone—NR3C1—polycystic ovary syndrome	0.000199	0.0181	CrCbGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000198	0.00246	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LHB—polycystic ovary syndrome	0.000197	0.00244	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000192	0.00239	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000186	0.00231	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SCT—polycystic ovary syndrome	0.000184	0.00229	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000182	0.00226	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IRS2—polycystic ovary syndrome	0.000176	0.00219	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000176	0.00218	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000173	0.00215	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—LEP—polycystic ovary syndrome	0.000173	0.00215	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000171	0.00213	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000169	0.0021	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—LSM5—polycystic ovary syndrome	0.000164	0.00204	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00016	0.00199	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000158	0.00196	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IRS1—polycystic ovary syndrome	0.000154	0.00191	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SAP30L—polycystic ovary syndrome	0.000153	0.0019	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—INSR—polycystic ovary syndrome	0.000151	0.00187	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PPARG—polycystic ovary syndrome	0.00015	0.00187	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—INS—polycystic ovary syndrome	0.000147	0.00183	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000143	0.00178	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IGF1—polycystic ovary syndrome	0.000143	0.00177	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP19A1—polycystic ovary syndrome	0.000143	0.013	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000141	0.00175	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PGR—polycystic ovary syndrome	0.00014	0.00174	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—SERPINE1—polycystic ovary syndrome	0.000135	0.00168	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—TEAD2—polycystic ovary syndrome	0.00013	0.00162	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00013	0.00161	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00013	0.00161	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000129	0.0016	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000124	0.00154	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000121	0.0015	CbGpPWpGaD
Fluocinonide—Dexamethasone—NR3C1—polycystic ovary syndrome	0.000116	0.0105	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000114	0.00142	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000114	0.00141	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PRL—polycystic ovary syndrome	0.000113	0.00141	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000113	0.0014	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000109	0.00136	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000107	0.00134	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	0.000106	0.00131	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP1A1—polycystic ovary syndrome	0.000105	0.00957	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—GNAS—polycystic ovary syndrome	9.96e-05	0.00124	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.49e-05	0.00118	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NRG1—polycystic ovary syndrome	9.31e-05	0.00116	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	9.31e-05	0.00116	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RPL37A—polycystic ovary syndrome	9.26e-05	0.00115	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—AR—polycystic ovary syndrome	8.76e-05	0.00109	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	8.05e-05	0.001	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IRS2—polycystic ovary syndrome	7.98e-05	0.000992	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LEP—polycystic ovary syndrome	7.81e-05	0.000971	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	7.66e-05	0.000952	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IRS1—polycystic ovary syndrome	6.96e-05	0.000866	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—POMC—polycystic ovary syndrome	6.71e-05	0.000834	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—INS—polycystic ovary syndrome	6.67e-05	0.000829	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IGF1—polycystic ovary syndrome	6.45e-05	0.000802	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT2—polycystic ovary syndrome	6.45e-05	0.000801	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IL6—polycystic ovary syndrome	6.44e-05	0.000801	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—YAP1—polycystic ovary syndrome	6.21e-05	0.000772	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.13e-05	0.000762	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	5.57e-05	0.000692	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	5.49e-05	0.000682	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—TNRC6B—polycystic ovary syndrome	5.48e-05	0.000681	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PGR—polycystic ovary syndrome	5.42e-05	0.000674	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	4.94e-05	0.000615	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL6—polycystic ovary syndrome	4.93e-05	0.000613	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AR—polycystic ovary syndrome	4.22e-05	0.000524	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.21e-05	0.000524	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NCOR1—polycystic ovary syndrome	3.69e-05	0.000458	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL6—polycystic ovary syndrome	2.91e-05	0.000362	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPARG—polycystic ovary syndrome	2.64e-05	0.000328	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SERPINE1—polycystic ovary syndrome	2.38e-05	0.000296	CbGpPWpGaD
